SCHEMBL8212482

SCHEMBL8212482

CCOC(=O)Cn1c(C)nc2c(c1=O)CC(C#N)(c1ccc(OC)c3oc4ccccc4c13)CC2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.36
RXFP1 Q9HBX9 1/20 0.36
CYP1A2 P05177 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
PDE4B Q07343 2/20 0.34
CYP17A1 P05093 1/20 0.34
CYP19A1 P11511 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
TNF P01375 1/20 0.33
LITAF Q99732 1/20 0.33
ALDH1A1 P00352 2/20 0.33
NPC1 O15118 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4537205 0.92 NPC1 (0.36) POLBPDE4BCYP17A1CYP19A1CYP11B1
SCHEMBL8201409 0.87 POLB (0.43) POLBRXFP1CYP1A2CYP2C9CYP2C19
SCHEMBL12316295 0.87 NPC1 (0.34) POLBRXFP1CYP1A2CYP2C9CYP2C19
SCHEMBL4011948 0.84 PDE4B (0.34) RXFP1PDE4BCYP17A1CYP19A1CYP11B1
SCHEMBL4519628 0.84 ALDH1A1 (0.36) CYP1A2CYP2C9CYP2C19PDE4BCYP17A1
SCHEMBL12342055 0.83 KDM4E (0.34) POLBRXFP1CYP1A2CYP2C9CYP2C19
SCHEMBL4017282 0.80 HDAC6 (0.44) POLBRXFP1CYP17A1CYP19A1CYP11B1
SCHEMBL14865170 0.79 LMNA (0.33) RXFP1PDE4BCYP17A1CYP19A1CYP11B1
SCHEMBL4017828 0.79 TNKS (0.35) PDE4BCYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL4524475 0.78 PDE4B (0.34) RXFP1PDE4BCYP17A1CYP19A1CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263648-B2 Diebenzofuran derivatives as inhibitors of PDE-4 and PDE-10 Mylan Laboratories Ltd. (IN) 2012-09-11 US disclosed
US-20090281131-A1 DIEBENZOFURAN DERIVATIVES AS INHIBITORS OF PDE-4 AND PDE-10 MYLAN LABORATORIES LIMITED (IN) 2009-11-12 US disclosed
WO-2008032171-A1 DIBENZOFURAN DERIVATIVES AS INHIBITORS OF PDE-4 AND PDE-10 MATRIX LABORATORIES LTD. (DE) 2008-03-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281131-A1 DIEBENZOFURAN DERIVATIVES AS INHIBITORS OF PDE-4 AND PDE-10 PDE4A, PDE4B, PDE12 POLB 1968/4885RXFP1 1097/4885CYP1A2 886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.